UK markets closed

Novo Nordisk A/S (NONOF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
126.52+0.06 (+0.05%)
As of 01:01PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close126.46
Open127.41
Bid0.00 x 0
Ask0.00 x 0
Day's range125.00 - 130.75
52-week range74.70 - 140.32
Volume25,254
Avg. volume43,352
Market cap578.833B
Beta (5Y monthly)0.19
PE ratio (TTM)47.21
EPS (TTM)2.68
Earnings date02 May 2024
Forward dividend & yield1.86 (1.47%)
Ex-dividend date22 Mar 2024
1y target estN/A
  • Yahoo Finance

    Novo Nordisk sales up 26% driven by GLP-1s, misses 11% on Wegovy

    Novo Nordisk CEO Lars Jørgensen tells Yahoo Finance the company is confident about a robust GLP-1 sales year despite missing Wall Street estimates.

  • Yahoo Finance Video

    Apple, Novo Nordisk earnings, jobless claims: What to watch

    A number of companies release their quarterly earning reports on Thursday, including Apple (AAPL), Novo Nordisk (NVO), Shell (SHEL), ConocoPhillips (COP), Cigna (CI), Coinbase (COIN), Moderna (MRNA), DraftKings (DKNG), Kellanova (K), United States Steel (X), and more. On the economic front, jobless claims for the week ending on April 27 will be released. Economists expect claims to rise to 212,000 from 207,000 the prior week. For more expert insight and the latest market action, click here to watch this full episode of Market Domination Overtime. This post was written by Nicholas Jacobino

  • Barrons.com

    Novo Nordisk’s Wegovy Sales More Than Doubled. Why the Stock Is Falling.

    The Danish pharmaceutical giant, which became Europe’s most valuable company last year, said Wegovy sales jumped 106% in the first quarter.